| Aarey Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524412 |
NSE Symbol : AAREYDRUGS |
P/E(TTM) : 86.18 |
|
ISIN Demat : INE198H01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.31 |
|
Book Value(₹) : 54.46 |
Market Cap(₹Cr) : 359.86 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 44.63 | 189.47 | 96.43 | 84.16 | 102.21 | 108.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 44.63 | 189.47 | 96.43 | 84.16 | 102.21 | 108.10 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.72 | -0.43 | 4.18 | 0.79 | 1.55 | 7.54 |
| Total Income | 46.34 | 189.04 | 100.61 | 84.95 | 103.76 | 115.64 |
| Total Expenditure | 43.30 | 185.13 | 97.94 | 81.52 | 100.51 | 112.30 |
| PBIDT | 3.04 | 3.91 | 2.67 | 3.44 | 3.25 | 3.33 |
| Interest | 1.67 | 1.78 | 0.92 | 1.26 | 1.04 | 1.30 |
| PBDT | 1.37 | 2.13 | 1.75 | 2.17 | 2.22 | 2.03 |
| Depreciation | 0.85 | 0.85 | 0.83 | 0.69 | 0.49 | 0.41 |
| Tax | 0.30 | -0.52 | 0.37 | 0.35 | 0.35 | 1.11 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.81 | 0.24 | -0.02 | 0.11 | 0.01 | 0.05 |
| Reported Profit After Tax | 1.02 | 1.56 | 0.57 | 1.02 | 1.37 | 0.47 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.02 | 1.56 | 0.57 | 1.02 | 1.37 | 0.47 |
| EPS (Unit Curr.) | 0.36 | 0.55 | 0.20 | 0.36 | 0.48 | 0.17 |
| EPS (Adj) (Unit Curr.) | 0.36 | 0.55 | 0.20 | 0.36 | 0.48 | 0.17 |
| Calculated EPS (Unit Curr.) | 0.36 | 0.55 | 0.20 | 0.36 | 0.49 | 0.17 |
| Calculated EPS (Adj) (Unit Curr.) | 0.36 | 0.55 | 0.20 | 0.36 | 0.49 | 0.17 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.44 | 2.19 | 0.80 | 1.44 | 1.96 | 0.67 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.44 | 2.19 | 0.80 | 1.44 | 1.96 | 0.67 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 28.45 | 28.45 | 28.45 | 28.45 | 28.05 | 28.05 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 116.63 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.81 | 2.06 | 2.77 | 4.09 | 3.18 | 3.08 |
| PBDTM(%) | 3.07 | 1.12 | 1.81 | 2.58 | 2.17 | 1.88 |
| PATM(%) | 2.29 | 0.82 | 0.59 | 1.21 | 1.34 | 0.43 |
